T1	Participants 475 551	patients who had at least one aura attack per month during the past 3 months
T2	Participants 973 1077	39 patients were included in the study, of whom 31 were included in the statistical analysis of efficacy
T3	Participants 410 471	40 mg tonabersat once daily was compared with matched placebo
